Immunic to host ms r&d day and participate in investor conferences in april

New york , april 4, 2024 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that it will host a multiple sclerosis (ms) research and development (r&d) day and participate in the following investor conferences in april: april 9: immunic's ms r&d day . management of immunic, including daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking